CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With or Without ID Derma Vax™ Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01697007
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:53.496616+00:00
Published At: 2015-06-29T00:00:00+00:00
Record Updated At: 2015-06-29
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Vaccines", "HIV", "Safety", "Immunogenicity"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-06-29"
protocolSection.identificationModule.nctId: "NCT01697007"
protocolSection.identificationModule.officialTitle: "A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet\u00ae With or Without ID Derma Vax\u2122 Electroporation Followed by IM MVA Boosting in Healthy Volunteers in Tanzania and Mozambique"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.